Evaluating Evidence in Lifestyle Medicine: A Practical Guide for Health Professionals in Viet Nam

Evaluating Evidence in Lifestyle Medicine: A Practical Guide for Health Professionals in Viet Nam

Last reviewed: 24 September 2026

Evidence-based practice is central to Lifestyle Medicine. But being evidence-based means more than finding a published study that supports a particular diet, exercise program, sleep intervention, or behavior-change strategy. It means asking whether the evidence is trustworthy, what question it actually answers, how large and clinically meaningful the effect is, how certain we can be about that effect, and whether the findings can reasonably be applied to the person or population in front of us.

This is particularly important in Lifestyle Medicine because the evidence base is broad and methodologically diverse. It includes randomized controlled trials, cohort studies, systematic reviews, meta-analyses, behavioral research, implementation studies, mechanistic research, population studies, and clinical practice guidelines. Some questions can be answered well by randomized trials. Others involve behaviors or exposures that develop over years or decades, making long-term randomization, blinding, or tightly controlled experimentation difficult, impractical, or sometimes unethical. The current Lifestyle Medicine Core Competencies explicitly include understanding the principles of evidence-based medicine and applying them to Lifestyle Medicine practice. The 2025 update expanded the framework from 88 to 89 competencies and strengthened attention to social determinants of health, planetary health, and the evidence surrounding food processing.

Evidence hierarchy matters, but it is not enough

Traditional evidence hierarchies often place systematic reviews and randomized controlled trials above observational studies. This remains useful for many clinical questions, particularly when we want to know whether a clearly defined intervention causes a particular outcome. Randomization can reduce confounding, and a well-conducted trial can provide strong causal evidence. But the label attached to a study does not, by itself, tell us whether the evidence is trustworthy.

A poorly conducted randomized trial may be less informative than a carefully designed prospective cohort study for some questions. A systematic review may appear authoritative but still be unreliable if the search was incomplete, important studies were missed, risk of bias was poorly assessed, substantial differences between studies were ignored, or selective publication distorted the available evidence. Good evidence appraisal therefore looks beyond study design to how the research was conducted, analyzed, reported, and synthesized.

Lifestyle research adds another challenge. It may be unrealistic or unethical to randomize people for decades to smoking versus not smoking, sustained physical inactivity versus regular activity, or certain long-term dietary exposures. Different questions therefore require different forms of evidence. The current Grading of Recommendations Assessment, Development and Evaluation approach recognizes this distinction. For questions about the effects of interventions, randomized trials are generally the preferred starting point, although non-randomized studies can provide important complementary evidence. For questions about exposures or prognostic factors, however, non-randomized studies are often the most appropriate design and are assessed accordingly rather than automatically being treated as inherently weak evidence.

The Hierarchies of Evidence Applied to Lifestyle Medicine framework was proposed in 2019 to explore how evidence from different research designs might be considered when assessing long-term lifestyle exposures and outcomes. It offers a useful perspective, but it should not be interpreted as a reason to lower methodological standards, treat observational associations as automatically causal, or replace established approaches to assessing risk of bias and certainty of evidence. The underlying principle is simpler: use the most appropriate evidence for the question and evaluate that evidence critically.

Start by asking what the study actually proves

One of the most important skills in reading Lifestyle Medicine research is separating related but different questions. Evidence that a behavior is associated with better health is not necessarily evidence that a particular clinical intervention will successfully change that behavior. And evidence that an intervention changes behavior is not automatically evidence that it improves long-term clinical outcomes.

Consider physical activity. Prospective studies may show that people who are more physically active have lower cardiovascular risk. A different question is whether a particular intervention delivered by a healthcare professional increases physical activity. A third question is whether that intervention ultimately reduces cardiovascular events. These questions are connected, but they are not the same, and they may require different study designs and different bodies of evidence.

This distinction has been debated directly in the recent peer-reviewed literature on lifestyle recommendations. Some authors have emphasized the substantial evidence linking lifestyle factors with chronic disease and the value of evidence-based lifestyle interventions. Others have argued that guideline developers need to distinguish more clearly between evidence that a healthy behavior is beneficial and evidence that a particular clinical intervention can produce and sustain that behavior change and improve outcomes. The practical lesson is not that clinicians need to choose one side of this debate. It is that we should be precise about what the available evidence actually supports.

A practical framework for evaluating Lifestyle Medicine evidence

1. Define the question before judging the evidence. Start with the population, the intervention or exposure, what it is being compared with, the outcomes that matter, and the relevant timeframe. A study involving healthy adults cannot automatically answer a question about people with established cardiovascular disease. A short-term weight-loss study cannot establish long-term cardiovascular benefit. Likewise, a study examining the association between a dietary pattern and mortality answers a different question from a trial evaluating a structured dietary intervention.

2. Ask whether the study design fits the question. Randomized controlled trials are particularly valuable for estimating the effects of defined interventions. Prospective cohort studies may be important when studying long-term behaviors, environmental exposures, or outcomes that take many years to develop. Qualitative research can help explain acceptability, barriers, and patient experiences. Implementation studies can tell us whether an intervention that worked under research conditions can be delivered effectively in real healthcare systems. No single design answers every question.

3. Look for risk of bias, not just the reputation of the journal. Consider how participants were selected, whether comparison groups were sufficiently similar, whether randomization and allocation were appropriately conducted when applicable, how much loss to follow-up occurred, whether outcomes were measured consistently, whether analyses were prespecified, and whether important results may have gone unreported. In observational research, confounding deserves particular attention. People who exercise regularly or follow healthier dietary patterns may also differ in income, education, smoking, sleep, healthcare use, or many other characteristics. Statistical adjustment can reduce some confounding, but it rarely guarantees that all confounding has been removed.

4. Look at the size and precision of the effect, not only statistical significance. A small effect can become statistically significant in a sufficiently large study, while a potentially important effect may remain uncertain in a small study. Look at effect sizes, absolute differences, and confidence intervals. Ask whether the difference is large enough to matter clinically. Relative effects should also be interpreted alongside absolute effects because an impressive relative reduction can correspond to a small absolute difference when baseline risk is low.

5. Distinguish surrogate outcomes from outcomes that matter directly to patients. Changes in body weight, blood pressure, glycated hemoglobin, lipid concentrations, or inflammatory biomarkers can be clinically useful, but they are not interchangeable with symptoms, physical functioning, quality of life, cardiovascular events, hospitalization, or mortality. The strength of a claim should reflect the outcome that was actually studied. Improvement in a biomarker should not automatically be translated into a claim that an intervention prevents clinical events unless the evidence supports that conclusion.

6. Evaluate the body of evidence, not one attractive study. Replication matters. Consistency across independent studies, populations, settings, and research methods generally provides greater confidence than one striking result. The Grading of Recommendations Assessment, Development and Evaluation approach provides a structured way to judge certainty in a body of evidence, considering factors such as risk of bias, inconsistency, indirectness, imprecision, and dissemination bias, including publication bias. Importantly, certainty in the evidence is not the same as the strength of a clinical recommendation. Recommendations also need to consider the balance of benefits and harms, patient values and preferences, resource use, equity, acceptability, feasibility, and context.

7. Ask about harms, burden, and opportunity cost. A lifestyle intervention should not automatically be assumed to be harmless simply because it does not involve a drug or procedure. Restrictive dietary approaches may create nutritional or psychological concerns for some people. Exercise prescriptions may require modification for people with cardiovascular, musculoskeletal, metabolic, or other conditions. Intensive programs may require substantial time, financial resources, family support, or professional supervision. There can also be opportunity costs when an unproven intervention delays or replaces treatment with established benefit. Potential benefits should therefore be considered alongside harms, treatment burden, adherence, feasibility, and available alternatives.

8. Consider conflicts of interest, but do not use them as a shortcut for judging evidence. Funding from an interested organization does not automatically make a study invalid, just as independent funding does not guarantee high-quality research. What matters is transparency, study design, prespecified methods, analysis, selective reporting, and whether findings have been independently replicated. Conflict-of-interest declarations are one part of critical appraisal, not a substitute for it. AMSTAR 2, for example, evaluates systematic reviews across a series of methodological domains and cautions against turning its individual items into a simple numerical score that could conceal important weaknesses.

9. Ask whether the evidence applies to people in Viet Nam. A study can be internally valid without being directly transferable to every healthcare setting. Baseline disease risk, dietary culture, food availability, family structure, occupation, socioeconomic conditions, the built environment, environmental exposures, healthcare access, and affordability may all influence effectiveness and implementation. This does not mean that evidence generated outside Viet Nam should be rejected. It means clinicians should consider how directly it applies and whether appropriate adaptation is needed.

This is increasingly recognized within the international Lifestyle Medicine framework. The 2025 Core Competencies introduced a specific competency on applying Lifestyle Medicine interventions in the context of social determinants of health to improve health outcomes and health equity. The accompanying discussion emphasizes social, economic, cultural, and structural influences, together with culturally relevant interventions, interdisciplinary collaboration, and community engagement. The governance framework published in 2026 goes further by establishing a globally representative process while explicitly allowing regional flexibility to reflect cultural and contextual differences.

10. Separate evidence from recommendations, and recommendations from scope of practice. Strong evidence does not mean that every patient should receive the same intervention. Clinical decisions still require consideration of the person's health conditions, risks, preferences, priorities, available alternatives, and ability to implement the intervention. Shared decision-making remains essential.

There is also an important legal and professional consideration in Viet Nam. Scientific evidence does not, by itself, expand a healthcare professional's authorized scope of practice or a healthcare facility's permitted professional activities. When lifestyle interventions form part of medical examination or treatment, their delivery must comply with applicable professional, licensing, institutional, and regulatory requirements. Vietnamese law also has a specific pathway for a “new technique” or “new method” in medical examination and treatment. Importantly, the Law defines this category as a technique or method being applied in Viet Nam for the first time, so this regulatory pathway should not be assumed to apply simply because an intervention is new to an individual practitioner or healthcare facility. Where the statutory definition is met, the facility must satisfy the relevant conditions and follow the prescribed process for pilot application and subsequent authorization. The current consolidated Law on Medical Examination and Treatment is Consolidated Document No. 26/VBHN-VPQH dated 26 February 2026. Detailed implementation is provided in Decree No. 96/2023/ND-CP, while professional scopes of practice are addressed in Circular No. 32/2023/TT-BYT, as subsequently amended, including by Circular No. 25/2026/TT-BYT, effective from 15 August 2026.

Systematic reviews and guidelines still need critical appraisal

Clinicians often have limited time to read individual studies, which makes systematic reviews and clinical practice guidelines valuable sources of synthesized evidence. But neither label guarantees quality. A systematic review should have a focused question, an appropriate and sufficiently comprehensive search strategy, transparent eligibility criteria, credible assessment of risk of bias, and a method of synthesis appropriate to the differences among the included studies. AMSTAR 2 provides a structured way to examine these features and cautions against generating a single numerical score from its individual items because this may obscure weaknesses in critical domains.

Guidelines require another level of judgment. Ask who developed the guideline, what evidence was considered, when the evidence search was conducted, how certainty was assessed, how conflicts of interest were managed, whether benefits and harms were considered, and whether the intended population resembles the patient or population in which the recommendation will be used. Certainty of evidence is important, but it is not the only factor determining a recommendation.

For everyday clinical reading, a simple approach can still be very effective. Ask whether the research question is clearly focused, whether valid methods were used, how large and important the results are, and whether they are applicable to the patient or population of interest. These questions help clinicians move beyond simply asking whether a study exists and toward understanding whether it should influence practice.

Be careful when claims go beyond the evidence

Health information related to nutrition, exercise, sleep, stress, fasting, supplements, and other lifestyle practices is widely available to both professionals and the public. Familiar or apparently “natural” interventions can sometimes sound intuitively safe or biologically plausible. But biological plausibility is not enough to establish clinical effectiveness.

Words such as “reverse,” “cure,” “prevent,” or “eliminate the need for medication” carry substantial clinical meaning. They should be used only when the evidence directly supports the claimed outcome in the relevant condition and population, with appropriate qualification about who achieved the outcome, under what intervention, over what period of time, and with what level of certainty. The same principle works in the other direction. Observational evidence should not be dismissed simply because it is not randomized, particularly when long-term randomization would be infeasible or unethical. Good evidence appraisal is not about accepting one type of study and rejecting another. It is about understanding what each design can and cannot tell us, and then judging the totality of evidence transparently.

From evidence to care

The goal of evidence-based Lifestyle Medicine is not to create certainty where certainty does not exist. It is to make better decisions while being clear about what we know, how confidently we know it, what remains uncertain, and what may change as new research emerges.

For health professionals in Viet Nam, a useful habit is to move beyond the question, “Is there a study supporting this?” Better questions are: What exactly was studied? How trustworthy were the methods? How large and clinically meaningful was the effect? How certain is the overall body of evidence? What are the potential harms and burdens? Does the evidence apply to this person and to the Vietnamese context? Is the proposed intervention consistent with current clinical guidance and within the relevant professional and regulatory scope?

That approach does more than protect against misinformation. It helps keep Lifestyle Medicine where it belongs, within evidence-based, patient-centered, and professionally accountable healthcare.

Selected references

1. Rea BL, Cheema S, Lanza S, et al. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. 2026;20(3):443-451. doi:10.1177/15598276251379821. First published online 28 October 2025.

2. Rea BL, Cheema S, Lanza S, et al. Governance and Update Process for Lifestyle Medicine Core Competencies and Definitions. American Journal of Lifestyle Medicine. 2026;20(7):1116-1123. doi:10.1177/15598276261424740. First published online 19 February 2026.

3. GRADE Working Group. GRADE Book. Current methodological guidance on assessing certainty of evidence and moving from evidence to recommendations.

4. Higgins JPT, Thomas J, Chandler J, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane.

5. Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomized studies of healthcare interventions, or both. BMJ. 2017;358:j4008. doi:10.1136/bmj.j4008.

6. Katz DL, Karlsen MC, Chung M, et al. Hierarchies of evidence applied to Lifestyle Medicine: introduction of a strength-of-evidence approach based on a methodological systematic review. BMC Medical Research Methodology. 2019;19:178. doi:10.1186/s12874-019-0811-z.

7. Johansson M, Niklasson A, Albarqouni L, et al. Guidelines recommending that clinicians advise patients on lifestyle changes: a popular but questionable approach to improve public health. Annals of Internal Medicine. 2024;177:1425-1427. doi:10.7326/ANNALS-24-00283.

8. Rosenfeld RM. Guidelines Recommending That Clinicians Advise Patients on Lifestyle Changes. Annals of Internal Medicine. 2025;178:1213. doi:10.7326/ANNALS-25-01850.

9. Centre for Evidence-Based Medicine, University of Oxford. Critical Appraisal Tools.

10. National Assembly of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15, as amended and consolidated in Consolidated Document No. 26/VBHN-VPQH dated 26 February 2026.

11. Government of Viet Nam. Decree No. 96/2023/ND-CP dated 30 December 2023 detailing a number of provisions of the Law on Medical Examination and Treatment.

12. Ministry of Health of Viet Nam. Circular No. 32/2023/TT-BYT dated 31 December 2023 detailing a number of provisions of the Law on Medical Examination and Treatment, as amended and supplemented, including by Circular No. 25/2026/TT-BYT dated 30 June 2026.

This article is intended for professional education and general information. It does not replace individualized clinical judgment, applicable clinical practice guidelines, professional licensing requirements, institutional requirements, or Vietnamese law.

Privacy Policy and Personal Data Protection Notice

Terms and Conditions

VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.

VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.

VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.